Ankur Shah, MD, PHD | |
8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 | |
(503) 659-1694 | |
(503) 659-1694 |
Full Name | Ankur Shah |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 8645 Se Sunnybrook Blvd Ste 200, Clackamas, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548678402 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD180084 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ankur Shah, MD, PHD 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 Ph: (503) 659-1694 | Ankur Shah, MD, PHD 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 Ph: (503) 659-1694 |
News Archive
Sen. Marco Rubio said he wouldn't vote for an increase unless it included "a plan for fundamental tax reform, an overhaul of our regulatory structure, a cut to discretionary spending, a balanced-budget amendment, and reforms to save Social Security, Medicare and Medicaid" — everything on the conservative agenda, basically.
The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it has filed a provisional patent application with the United States Patent and Trademark Office for a combination therapy of its lead compound, ORMD-0801 in combination with its oral exenatide formulation, ORMD-0901. There is no such approved combination product available on the market today.
› Verified 4 days ago
Pooja Banginwar, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015 Phone: 503-659-1694 Fax: 503-659-8984 | |
Jay Joo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 | |
Dr. Bonnie Jean Aust, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Office, Clackamas, OR 97015 Phone: 503-652-2880 | |
Dr. Patricia Theresa Campbell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-3418 | |
Mary Kathryn Brown, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9290 Se Sunnybrook Blvd, Suite 200, Clackamas, OR 97015 Phone: 503-659-1694 Fax: 503-659-8984 | |
Dr. Tracy Jeanne Peck, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 Fax: 503-571-3418 | |
Nancy Tran Chen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015 Phone: 503-659-1694 Fax: 503-659-8984 |